Organization · Venture Capital
Kaleida Capital
Kaleida Capital is an early-stage venture capital firm based in San Diego, California, specializing in neurotechnology and artificial intelligence. The firm invests in companies developing brain-inspired technologies, including neural engineering and brain-computer interfaces.
Overview
What Kaleida Capital does
What Kaleida Capital is
Kaleida Capital is an early-stage venture capital firm based in San Diego, California, specializing in neurotechnology and artificial intelligence. The firm invests in companies developing brain-inspired technologies, including neural engineering and brain-computer interfaces.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 6, 2026
Official channels
Find Kaleida Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Kaleida Capital as a funder
Investment thesis
Kaleida Capital invests at the intersection of brain science and artificial intelligence, focusing on neurotechnology and cognitive systems. The firm supports early-stage companies developing breakthrough technologies in neural data infrastructure, precision neuroscience, and digital interfaces.
Focus narrative
Kaleida Capital primarily invests in the neurotechnology and AI sectors, concentrating on areas such as neural data infrastructure, human performance, and digital interfaces. The firm targets early-stage companies that are developing transformative technologies in neural engineering and brain-computer interfaces, with a commitment to fostering innovation that has a significant impact on human health and capabilities.
Value beyond capital
Kaleida Capital adds value to its portfolio companies through deep technical diligence, scientific expertise, and a strong network in the neurotechnology and AI sectors. The firm supports founders with research-driven IP and clear clinical or commercial pathways, providing guidance and resources to help navigate the complexities of developing advanced technologies.
Focus and fit
- Stages
- Seed · Series A
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Kaleida Capital's portfolio includes notable companies such as Synchron, a clinical-stage brain-computer interface company; Manifest Technologies, an AI-powered computational neuroimaging platform; and Resonant Link Medical, which focuses on wireless power delivery for implantable medical devices. Other portfolio highlights include a prosthetic retina for vision restoration and a company revolutionizing neural data infrastructure.
Common questions
What to know about Kaleida Capital
Upseed classifies Kaleida Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.